Accel Wealth Management International Stem Cell Corp Transaction History
Accel Wealth Management
- $263 Million
- Q3 2024
About International Stem Cell CORP
- Ticker ISCO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,004,390
- Market Cap $480K
- Description
- International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, incl...